Vote — approved

Jack Sellers	yes
Thomas Galvin	yes
Bill Gates	yes
Steve Gallardo	yes

Ayes: Jack Sellers, Thomas Galvin, Bill Gates, Clint Hickman, Steve Gallardo

Item Text

50. NOTICE OF AWARD TO ACCEPT FUNDING FROM THE CENTER'S FOR DISEASE CONTROL AND PREVENTION FOR EPIDEMIOLOGY AND LAB CAPACITY Approve the Notice of Award (NOA) 1 NU51CK000383-01-00 and acceptance of new grant funds from The Center's for Disease Control and Prevention (CDC) in the amount not-to-exceed $2,258,875.00 per year. This grant is to support Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC). The grant award begins on August 01, 2024, and ends July 31, 2029. Authorize the Chairman to sign all documents related to these grant funds, as applicable. This grant deviates from County Policy A2505 and does not allow for full indirect cost reimbursement, but a maximum of 10%. The full indirect costs are estimated at $324,251.24 of which $205,352.27 is recoverable and $118,898.97 is unrecoverable. Program costs not covered by the grant will be subsidized by the MCDPH indirect cost pool. Departmental indirect rates are re-established at the beginning of each fiscal year and the future indirect rates will be collected at the corresponding rates. This grant is competitive, and it is unknown whether the grant will be awarded again. It should be noted that this grant award has not been awarded to Department of Public Health in previous years. There is no in-kind match requirement, and the grant does not require on-going cash contributions. The grant award is not a mandated function but provides a benefit to citizens by preventing and controlling emerging infectious diseases. Grant revenues are not local revenues for the purpose of the constitutional expenditure limitation, and therefore, expenditure of the funds is not prohibited by the budget law. Approval of this action does not alter the budget constraining the expenditure of local revenues duly adopted by the Board pursuant to A.R.S. §42-17105. (C-86-25-005-X-00)

Attachments (1)

Vote — approved

Jack Sellers	yes
Thomas Galvin	yes
Bill Gates	yes
Clint Hickman	yes
Steve Gallardo	yes

Ayes: Jack Sellers, Thomas Galvin, Bill Gates, Clint Hickman, Steve Gallardo

Item Text

72. NOTICE OF AWARD TO ACCEPT SUPPLEMENTAL GRANT FUNDING FROM THE CENTER'S FOR DISEASE CONTROL AND PREVENTION FOR EPIDEMIOLOGY AND LAB CAPACITY Approve the Notice of Award (NOA) 6 NU51CK000383-01-01 and acceptance of supplemental grant funds from The Center's for Disease Control and Prevention (CDC) in the amount not-to-exceed $968,313.00. This grant is to support Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC). The grant award begins on August 01, 2024, and ends July 31, 2029. The budget period for the supplemental funds is August 01, 2024, and ends July 31, 2025. This grant deviates from County Policy A2505 and does not allow for full indirect cost reimbursement, but a maximum of 10%. The full indirect costs are estimated at $138,996.93 of which $88,028.45 is recoverable and $50,968.48 is unrecoverable. Program costs not covered by the grant will be subsidized by the MCDPH indirect cost pool. Departmental indirect rates are re-established at the beginning of each fiscal year and the future indirect rates will be collected at the corresponding rates. This grant is competitive, and it is unknown whether the grant will be awarded again. It should be noted that this grant award has not been awarded to Department of Public Health in previous years. There is no in-kind match requirement, and the grant does not require on-going cash contributions. The grant award is not a mandated function but provides a benefit to citizens by preventing and controlling emerging infectious diseases. Grant revenues are not local revenues for the purpose of the constitutional expenditure limitation, and therefore, expenditure of the funds is not prohibited by the budget law. Approval of this action does not alter the budget constraining the expenditure of local revenues duly adopted by the Board pursuant to A.R.S. §42-17105. (C-86-25-005-X-01)

Attachments (1)

Vote — approved

Thomas Galvin	yes
Kate Brophy McGee	yes
Mark Stewart	yes
Steve Gallardo	yes
Debbie Lesko	absent

Ayes: Thomas Galvin, Kate Brophy McGee, Mark Stewart, Steve Gallardo Absent: Debbie Lesko

Item Text

101. NOTICE OF AWARD TO ACCEPT GRANT FUNDS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION FOR EPIDEMIOLOGY AND LAB CAPACITY Approve the retroactive Notice of Award (NOA) 5 NU51CK000383-02-00 and acceptance of grant funds from The Centers for Disease Control and Prevention (CDC) in the amount not-to-exceed $1,598,892.00. This grant is to support Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC). The non-competing continuation award period begins on August 01, 2025, and ends July 31, 2026. The original term of the grant began on August 01, 2024, and ends July 31, 2029. This grant deviates from County Policy A2505 and does not allow for full indirect cost reimbursement, but a maximum of 10%. The full indirect costs are estimated at $242,595.52 of which $145,353.82 is recoverable and $97,241.70 is unrecoverable. Program costs not covered by the grant will be subsidized by the MCDPH indirect cost pool. This grant is competitive, and it is unknown whether the grant will be awarded again. It should be noted that this grant award has not been awarded to Department of Public Health in previous years. There is no in-kind match requirement, and the grant does not require on-going cash contributions. The grant award is not a mandated function but provides a benefit to citizens by preventing and controlling emerging infectious diseases. Grant revenues are not local revenues for the purpose of the constitutional expenditure limitation, and therefore, expenditure of the funds is not prohibited by the budget law. Approval of this action does not alter the budget constraining the expenditure of local revenues duly adopted by the Board pursuant to A.R.S. §42-17105. (C-86-25-005-X-02)

Vote — approved

Thomas Galvin	yes
Kate Brophy McGee	yes
Mark Stewart	yes
Debbie Lesko	yes
Steve Gallardo	yes

Ayes: Thomas Galvin, Kate Brophy McGee, Mark Stewart, Debbie Lesko, Steve Gallardo

Item Text

99. NOTICE OF AWARD TO ACCEPT GRANT FUNDS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION FOR EPIDEMIOLOGY AND LAB CAPACITY Approve the retroactive Notice of Award (NOA) 6 NU51CK000383-02-01and acceptance of grant funds from The Centers for Disease Control and Prevention (CDC) in the not-to-exceed amount of $722,226.00. This grant is to support Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC). This NOA was issued by the CDC on September 24, 2025. This is a partial NOA that brings the total funding for this budget period up to the not-to-exceed amount of $2,321,118.00. The supplemental award period began on August 01, 2025, and ends July 31, 2026. The original term of the grant began on August 01, 2024, and ends July 31, 2029. This grant deviates from County Policy A2505 and does not allow for full indirect cost reimbursement, but a maximum of 10%. The full indirect costs are estimated at $109,581.38 of which $65,656.91 is recoverable and $43,924.47 is unrecoverable. Program costs not covered by the grant will be subsidized by the MCDPH indirect cost pool. This grant is competitive, and it is unknown whether the grant will be awarded again. It should be noted that this grant award has not been awarded to Department of Public Health in previous years. There is no in-kind match requirement, and the grant does not require on-going cash contributions. The grant award is not a mandated function but provides a benefit to citizens by preventing and controlling emerging infectious diseases. Grant revenues are not local revenues for the purpose of the constitutional expenditure limitation, and therefore, expenditure of the funds is not prohibited by the budget law. Approval of this action does not alter the budget constraining the expenditure of local revenues duly adopted by the Board pursuant to A.R.S. §42-17105. (C-86-25-005-X-03)

Attachments (1)